Members of the ACCC IO Institute Executive Committee discuss why care coordination and communication among the IO team, other providers, and the patient is critical for effective delivery of immunotherapy for cancer. (features Mark Faries, MD; Sanjiv Agarwala, MD; and Niesha Griffith, MS, RPh, FASHP)
Learn about the mental health implications of treatment with cancer immunotherapy, and how cancer care providers can better integrate mental health awareness into the IO care continuum.
Discover the results of the 2019 Trending Now in Cancer Care Survey—what tops the list of challenges, what areas are trending towards growth, and how cancer programs are evolving to meet the demands of 21st-century cancer care delivery.
We sat down with journalist Mary Elizabeth Williams, one of the first patients treated with combination immunotherapy, to discuss her experience as an IO patient and how to bridge communication gaps among patients, doctors, and researchers.
Learn why a trip to the emergency department is different for patients who receive immunotherapy for cancer, what information helps ED clinicians, and what busy emergency department providers need to know about immune-related adverse events.
Download Article & Companion Guide